AEVA: Ridiculous Valuation for a Bleeding Startup Masquerading as AI – Fugazi Research

Filings show Aeva trades at roughly 72x FY2025 sales while losing $9.24 for every $1 of revenue it books.

Five and six trading days after Aeva announced a hyperscaler optical-connectivity deal on August 5, 2026, its CEO and CTO sold a combined 405,099 shares for approximately $9.79 million, near the peak of the post-announcement rally. That sum is almost as large as the $12.4 million of revenue Aeva reported for the entire first half of 2026. The wider finding: Aeva carries a roughly $1.3 billion market capitalization against $18.1 million of fiscal 2025 revenue, a company its own 10-K says has made only "immaterial commercial deliveries." Fugazi Research, which holds a short position in Aeva, argues the stock is priced for a scaled commercial business it has not yet become.

Ticker: AEVA (Aeva Technologies, Inc.)
Research Firm: Fugazi Research
Report URL: https://www.fugaziresearch.com/p/aeva-ridiculous-valuation-for-a-bleeding?ref=shortreport.fyi
Position Disclosure: Fugazi Research holds a short position in Aeva Technologies, Inc.

Thesis

Fugazi Research, drawing on Aeva's SEC filings, argues the stock's price has decoupled from an operating business that remains pre-commercial.

• Valuation Disconnect: Aeva carried roughly $1.3 billion in market capitalization as of August 19-20, 2026 against $18.1 million of fiscal 2025 revenue, or about 72x sales; the 2025 10-K states Aeva has "primarily sold or otherwise provided prototypes and non-recurring engineering services," made only "immaterial commercial deliveries," and offers no assurance broad-based deliveries occur in 2026 or ever.
• Losses Outpace Revenue: Net losses totaled roughly $447.0 million across 2023-2025; the June 30, 2026 10-Q reports a $114.6 million first-half loss on $12.4 million of revenue, an $871.9 million accumulated deficit and just $27.5 million of stockholders' equity.
• Partnership Parade, No Revenue: Years of announced ties to Audi, ZF, Denso, Plus, NVIDIA, Daimler/Torc, SICK, Railergy, Forterra and NASA have not moved Aeva past the point where its own 10-K says it has not commercialized products in a material amount, noting automotive development cycles can run seven years or more.
• Hyperscaler Deal Lacks Volume: The August 5, 2026 8-K disclosing an Optical Connectivity business and a joint development agreement targets an initial hyperscaler deployment in the second half of 2027 and a production ramp in 2028, with no committed volume disclosed; the stock rose from roughly $19 to above $24 on the announcement.
• "Order Book" Isn't Backlog: Aeva's 10-K defines its Order Book as a forward-looking, cumulative billing estimate based on projected pricing and take rates, and states customers make no contractual commitment until testing, validation, integration and readiness determinations are complete, with no assurance those estimates convert to definitive agreements.
• Concentrated Customer Base: Three customers accounted for 64% of fiscal 2025 revenue, two customers for 72% of fiscal 2024 revenue, and two customers for 59% of revenue in the six months ended June 30, 2026.
• Financed by Dilution: Aeva raised roughly $108.8 million net from a $115 million June 2026 equity offering, holds a standby facility for up to $125 million of convertible preferred stock through November 8, 2026, and carries $100 million of 4.375% convertible notes due 2032 held by Apollo Global Securities; shares outstanding rose 10.7%, from 62.9 million to 69.7 million, in under five months.
• Selling Into the Spike: CEO Soroush Salehian Dardashti, CTO Mina Rezk and departing CFO Saurabh Sinha together account for roughly $11.9 million of insider sales over the trailing three months, including Sinha's $1.48 million sale disclosed alongside a September 5, 2026 resignation; all trades were executed under Rule 10b5-1 plans, with no offsetting open-market purchases.

Catalysts

• November 8, 2026: Expiration of Aeva's up-to-$125 million Sylebra standby preferred facility; renewal, drawdown or lapse would signal how reliant the company remains on equity-linked financing.
• September 5, 2026: CFO Saurabh Sinha's resignation takes effect; his successor and any related disclosures could affect confidence in financial reporting.
• Second half of 2027: Targeted initial hyperscaler deployment under the August 2026 Near-Packaged Optics agreement; a confirmed customer deployment or a delay would be the first real test of the deal's substance.
• 2028: Targeted production ramp for the optical-connectivity program; evidence of committed volume (or its absence) would clarify whether the business becomes revenue-generating.
• Ongoing: Future customer testing, validation and integration decisions that determine whether Order Book estimates convert into definitive production agreements, cancellations or postponements.
• 2032: Maturity of Aeva's $100 million, 4.375% convertible senior notes held by Apollo Global Securities; the notes' conversion or refinancing terms could affect future dilution.

Company Response

The report does not describe a request for comment made to Aeva, and no response from the company is reported.

Notable Details

• Aeva spent $85.4 million on R&D in fiscal 2025, nearly five times its entire $18.1 million of annual revenue, even after R&D spending fell from $102.7 million in 2024.
• Aeva, its co-founders and SPAC sponsor Ahmed Fattouh settled Delaware stockholder litigation over the 2021 merger's proxy materials for $14 million in December 2024, without admitting liability.
• Aeva has built its commercial thesis around FMCW lidar even as Tesla has rejected lidar for camera-based autonomy and Mobileye ended its internal next-generation FMCW lidar development in September 2024, a wind-down affecting roughly 100 employees.
• Following the August 2026 announcement, Oppenheimer, one of three joint book-running managers on Aeva's June 2026 offering, floated the possibility of billions of dollars in future orders, according to the report.

"The stock market pays for the noun; the filing discloses the conditions."

This line appears in Fugazi Research's "valuation by adjacency" argument, capturing its view that investors reward Aeva's association with fashionable markets while its SEC filings disclose the commercial contingencies attached to them.

FAQs

What does AEVA's stock price imply about its revenue multiple?

At roughly $18.87 per share on August 20, 2026, Aeva's market capitalization of about $1.32 billion implied approximately 72x trailing fiscal 2025 revenue, 53x annualized first-half 2026 revenue, or 39x the fiscal 2026 guidance midpoint, per the company's 10-K and 10-Q filings.

What does Aeva Technologies, Inc. actually sell today?

Per its 2025 Form 10-K, Aeva has primarily sold prototypes and non-recurring engineering services and has made only "immaterial commercial deliveries," with no assurance that broad-based commercial deliveries occur in 2026 or at all.

What does Fugazi Research allege about Aeva's insider selling?

Fugazi Research alleges that CEO Soroush Salehian Dardashti and CTO Mina Rezk sold 405,099 shares for approximately $9.79 million on August 10-11, 2026, near the peak of the post-announcement rally, and that aggregate insider sales over the trailing three months reached approximately $11.9 million with no offsetting open-market purchases.

What is Aeva's "Order Book" and does it represent signed contracts?

Aeva's 10-K defines its Order Book as a forward-looking, cumulative billing estimate based on projected pricing and estimated take rates, not binding backlog. The filing states customers make no contractual commitment until testing, validation, integration and readiness determinations are complete, and there is no assurance those estimates convert into definitive volume agreements.

How is Aeva funding its losses?

Aeva closed a $115 million public equity offering on June 5, 2026, generating $108.8 million in net proceeds, and maintains a standby facility for up to $125 million of convertible preferred stock through November 8, 2026, alongside $100 million of 4.375% convertible notes due 2032 held by Apollo Global Securities. Shares outstanding rose from 62.9 million to 69.7 million between March and July 2026.

What is the LG Innotek relationship and why does the report flag it?

Aeva entered a strategic collaboration with LG Innotek in May 2025 involving up to $50 million for joint product development. The report notes LG Innotek also invested in Aeva, received discounted equity, and became a manufacturing partner, and says the underlying investment and private-placement agreements require further review before the relationship is characterized further.

Did Aeva's August 2026 hyperscaler announcement involve a signed customer contract?

No. Aeva's August 5, 2026 Form 8-K describes a joint development agreement targeting an initial deployment in the second half of 2027 and a production ramp in 2028, with no committed volume disclosed, according to the filing.

What legal settlement involves Aeva's founders and its original SPAC sponsor?

Aeva, co-founders Soroush Salehian Dardashti and Mina Rezk, and SPAC sponsor Ahmed Fattouh settled Delaware Court of Chancery litigation for $14 million in December 2024 over claims that InterPrivate Acquisition Corp.'s 2021 merger proxy materials were false or misleading; the settlement did not include an admission of liability.

Disclaimer: This summary is not primary research and does not constitute investment advice. It is a brief overview of a detailed equity research report authored by the firm, organization, or source referenced in this article or at https://www.fugaziresearch.com/p/aeva-ridiculous-valuation-for-a-bleeding, which contains extensive evidence, regulatory filings, and analysis; readers are encouraged to review the full report there for a comprehensive understanding. The content provided in this publication is not authored or originated by us — we act solely as a distributor and do not endorse, verify, or take responsibility for the accuracy, completeness, or reliability of the information presented. This publication is for informational purposes only and should not be construed as legal, business, investment, or tax advice. Always conduct independent due diligence and consult qualified professionals before making any decisions based on the information contained herein. We disclaim all liability for any loss or damage arising from reliance on third-party content, and the views expressed are solely those of the respective source and do not necessarily reflect our own.